Singapore markets closed
  • Straits Times Index

    3,186.11
    -8.93 (-0.28%)
     
  • S&P 500

    3,941.48
    -32.27 (-0.81%)
     
  • Dow

    31,928.62
    +48.38 (+0.15%)
     
  • Nasdaq

    11,264.45
    -270.83 (-2.35%)
     
  • BTC-USD

    29,760.46
    +548.69 (+1.88%)
     
  • CMC Crypto 200

    663.18
    +7.35 (+1.12%)
     
  • FTSE 100

    7,510.15
    +25.80 (+0.34%)
     
  • Gold

    1,855.10
    -10.30 (-0.55%)
     
  • Crude Oil

    110.85
    +1.08 (+0.98%)
     
  • 10-Yr Bond

    2.7600
    0.0000 (0.00%)
     
  • Nikkei

    26,677.80
    -70.34 (-0.26%)
     
  • Hang Seng

    20,171.27
    +59.17 (+0.29%)
     
  • FTSE Bursa Malaysia

    1,535.56
    +4.26 (+0.28%)
     
  • Jakarta Composite Index

    6,883.50
    -30.64 (-0.44%)
     
  • PSE Index

    6,597.76
    +20.31 (+0.31%)
     

Why Atea Pharmaceuticals Stock Is Sinking Today

·2-min read
Why Atea Pharmaceuticals Stock Is Sinking Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Atea Pharmaceuticals (NASDAQ: AVIR) fell by as much as 14.4% in premarket trading Wednesday morning. The biotech's shares are sliding today in response to Roche's (OTC: RHHBY) decision to terminate its involvement in the development of the oral COVID-19 therapy known as AT-527. Atea Pharmaceuticals will reportedly regain full commercial rights to the drug on Feb. 10, 2022.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting